epilepsy%20(pediatric)
EPILEPSY (PEDIATRIC)
Epileptic seizure is a transient occurrence of signs or symptoms that is due to abnormal excessive or synchronous neuronal activity in the brain.
Epilepsy is a disorder that is characterized by a persistent predisposition of the brain to generate epileptic seizures.
This condition may cause neurobiologic, cognitive, psychological and social disturbances.
It is recommended that all patients having a first seizure be referred to a specialist as soon as possible.

Epilepsy (Pediatric) Drug Information

Drug Information

Indication: Control of tonic-clonic (grand mal) status epilepticus. Prevention & treatment of seizures during or follo...

Indication: Adjunctive therapy in treatment of partial seizures w/ & w/o secondary generalization in adults & chil...

Indication: Monotherapy in patients w/ newly diagnosed epilepsy or for conversion to monotherapy in patients w/ epilepsy. ...

Indication: Monotherapy for partial seizures w/ or w/o secondary generalisation in adults w/ newly diagnosed epilepsy. Adj...

Indication: Anxiety, acute alcohol w/drawal symptoms, pre-op procedures to relieve anxiety & tension; adjunct prior to...

Indication: Control of generalised tonic-clonic (grand mal) epilepsy & psychomotor seizures.

Indication: Control of tonic-clonic (grand mal) status epilepticus. Prevention & treatment of seizures occurring durin...

Indication: Adjunctive treatment of partial-onset seizures w/ or w/o secondarily generalized seizures in patients ≥12 y...

Indication: Adjunctive treatment of seizures associated w/ Lennox-Gaustaut syndrome in adults & childn ≥4 yr.

Indication: Monotherapy in treatment of partial onset seizures w/ or w/o secondary generalisation in patients from 16 yr w...

1  /  5
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Audrey Abella, 14 Oct 2020
Findings from the phase IIa T1GER study revealed the therapeutic potential of the monoclonal antibody golimumab for children and young adults with type 1 diabetes (T1D).